Friday 6 November 2026
Export SYK’s income statement to Excel — free account
Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.
- Revenue
- +7.64%
- EPS
- −12.4%
- Free cash flow
- −19.4%
- Total debt
- −10.0%
Quarter to September 2026, against a year earlier
324.26
10.82
−3.23%
Follow SYK
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 16.02% | 16.51% | 15.20% | 15.08% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
8 | 7 | 7 | 5 | |
| 7.68% | 7.91% | 7.23% | 7.15% | ||
ROIC |
9.67% | 9.76% | 8.97% | 8.94% | |
Return on Tangible Assets |
30.87% | 31.89% | 30.59% | 29.95% | |
Average Days of Receivables |
51.25 | 52.88 | 51.58 | 58.70 | |
Free Cash Flow per Share |
11.53 | 12.26 | 11.94 | 11.21 | |
Free Cash Flow |
4,408.00 | 4,702.00 | 4,571.00 | 4,283.00 | |
Capital Expenditures |
(1,038.00) | (823.00) | (804.00) | (761.00) | |
| Other line items | |||||
Cash ROIC |
10.58% | 11.09% | 11.24% | 10.11% | |
Accounts Receivable Turnover |
7.17 | 6.75 | 6.71 | 6.26 | |
Accounts Payable Turnover |
5.82 | 5.83 | 5.98 | 5.20 | |
Inventory Turnover |
1.64 | 1.67 | 1.74 | 1.80 | |
Average Days of Payables |
65.42 | 67.08 | 63.58 | 72.55 | |
Days of Inventory on Hand |
230.11 | 222.69 | 216.43 | 214.14 | |
Tax Rate |
(0.29) | (0.28) | (0.27) | (0.28) | |
Research and Development Expense of Revenue |
6.39% | 6.42% | 6.45% | 6.46% | |
Selling, General and Administrative Expense of Revenue |
34.41% | 33.99% | 34.16% | 34.44% | |
Share Based Compensation of Revenue |
0.97% | 0.97% | 0.97% | 0.97% | |
Interest Coverage |
9.27 | 9.22 | 8.07 | 8.05 | |
Operating CF/Net income |
1.50 | 1.48 | 1.61 | 1.55 | |
Depreciation/Fixed assets |
0.30 | 0.31 | 0.31 | 0.31 | |
Capex/Depreciation |
(0.86) | (0.67) | (0.66) | (0.64) | |
Revenue per Share |
68.81 | 67.37 | 66.00 | 65.71 | |
Operating CF per Share |
14.25 | 14.41 | 14.04 | 13.20 | |
Capex per Share |
(2.72) | (2.15) | (2.10) | (1.99) | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026